Ramaekers J G, Berghaus G, van Laar M, Drummer O H
Experimental Psychopharmacology Unit, Department of Neurocognition, Faculty of Psychology, Maastricht University, P.O. Box 616, MD 6200 Maastricht, The Netherlands.
Drug Alcohol Depend. 2004 Feb 7;73(2):109-19. doi: 10.1016/j.drugalcdep.2003.10.008.
The role of Delta(9)-tetrahydrocannabinol (THC) in driver impairment and motor vehicle crashes has traditionally been established in experimental and epidemiological studies. Experimental studies have repeatedly shown that THC impairs cognition, psychomotor function and actual driving performance in a dose related manner. The degree of performance impairment observed in experimental studies after doses up to 300 microg/kg THC were equivalent to the impairing effect of an alcohol dose producing a blood alcohol concentration (BAC) >/=0.05 g/dl, the legal limit for driving under the influence in most European countries. Higher doses of THC, i.e. >300 microg/kg THC have not been systematically studied but can be predicted to produce even larger impairment. Detrimental effects of THC were more prominent in certain driving tasks than others. Highly automated behaviors, such as road tracking control, were more affected by THC as compared to more complex driving tasks requiring conscious control. Epidemiological findings on the role of THC in vehicle crashes have sometimes contrasted findings from experimental research. Case-control studies generally confirmed experimental data, but culpability surveys showed little evidence that crashed drivers who only used cannabis are more likely to cause accidents than drug free drivers. However, most culpability surveys have established cannabis use among crashed drivers by determining the presence of an inactive metabolite of THC in blood or urine that can be detected for days after smoking and can only be taken as evidence for past use of cannabis. Surveys that established recent use of cannabis by directly measuring THC in blood showed that THC positives, particularly at higher doses, are about three to seven times more likely to be responsible for their crash as compared to drivers that had not used drugs or alcohol. Together these epidemiological data suggests that recent use of cannabis may increase crash risk, whereas past use of cannabis does not. Experimental and epidemiological research provided similar findings concerning the combined use of THC and alcohol in traffic. Combined use of THC and alcohol produced severe impairment of cognitive, psychomotor, and actual driving performance in experimental studies and sharply increased the crash risk in epidemiological analyses.
传统上,δ-9-四氢大麻酚(THC)在导致驾驶员机能受损和机动车碰撞事故方面的作用是通过实验和流行病学研究确定的。实验研究反复表明,THC会以剂量相关的方式损害认知、精神运动功能和实际驾驶表现。在实验研究中,给予高达300微克/千克THC剂量后观察到的机能损害程度,等同于血液酒精浓度(BAC)≥0.05克/分升的酒精剂量所产生的损害效果,这是大多数欧洲国家酒后驾车的法定限量。更高剂量的THC,即>300微克/千克THC尚未得到系统研究,但可以预计会产生更大的损害。THC的有害影响在某些驾驶任务中比其他任务更为突出。与需要有意识控制的更复杂驾驶任务相比,高度自动化的行为,如道路跟踪控制,受THC的影响更大。关于THC在车辆碰撞事故中作用的流行病学研究结果有时与实验研究结果相矛盾。病例对照研究一般证实了实验数据,但罪责调查显示,几乎没有证据表明仅使用大麻的撞车司机比不吸毒的司机更有可能导致事故。然而,大多数罪责调查是通过检测血液或尿液中THC的无活性代谢物来确定撞车司机中是否使用过大麻的,吸烟后数天仍可检测到该代谢物,且只能作为过去使用过大麻的证据。通过直接测量血液中的THC来确定近期是否使用过大麻的调查显示,与未使用毒品或酒精的司机相比,THC呈阳性者,尤其是高剂量者,其撞车事故的责任可能性大约高出三至七倍。这些流行病学数据共同表明,近期使用大麻可能会增加撞车风险,而过去使用大麻则不会。关于在交通中同时使用THC和酒精的情况,实验和流行病学研究得出了类似的结果。在实验研究中,THC和酒精的同时使用会严重损害认知、精神运动和实际驾驶表现,在流行病学分析中则会大幅增加撞车风险。